|Day Low/High||53.05 / 54.07|
|52 Wk Low/High||40.44 / 60.52|
On Thursday, investors await quarterly earnings from Alphabet and Starbucks.
Jim Cramer reacts to DuPont's latest earnings report.
President Donald Trump will have breakfast today with auto executives as he continues to push for more U.S. manufacturing jobs.
I think then market's falling simply because the president's tone is purely protectionist.
Here's how to use charts to trade five stocks, including Dow Chemical and Honeywell.
This number is arbitrary, but for those who have latched onto it, here is a possible scenario that could get us there.
A WWF report shows how fragile our hold on the world's ecology is. Does Asia represent the future of food production?
Are you sitting down? Here is a really bullish chart.
Several companies, like Dow Chemical and GM, are reporting increases in their China business, which Jim Cramer says is a trend to watch.
Defense is fantastic, housing is so-so, timber's weaker. Who can understand this stuff?
This is new doctrine having to do with innovation and the stifling of innovation to create new products.
Regulatory issues will weigh on this deal, because of populist politics.
Prospective deals are hijacking an earnings-based focus on fundamentals.
For starters, trouble for banks, drugs, energy and M&A.
Dow Chemical rose more than 10% Monday after EU officials resumed their investigation into the company's proposed $130 million merger with DuPont.
Staying real, being transparent and honest. I made an important tactical move this afternoon -- close to the day's low. Talking Deutsche Bank in my Diary and in Barron's, I expect a capital raise (possibly rights offering, after a DOJ settlement). ...
Tesla shares rise after the company reports a record number of quarterly deliveries.
I suspect DuPont shares will trade a bit better in the near term after news that a timetable has been established in the restart of the European Union review of its planned merger with Dow Chemical . DuPont remains my favorite large-capitalization l...
Jim Cramer is skeptical the Dow Chemical merger with DuPont will be approved by regulators.
Dow Chemical and Dupont's proposed merger could face regulatory hurdles in Europe as regulators paused their review of the deal due to insufficient information provided by the companies.
Bayer increases its latest offering to entice Monsanto, as regulators look closely at agribusiness mergers.
The proposed merger between Dow Chemical and DuPont could be in jeopardy.
Jim Cramer says he doesn't think the Monsanto and Bayer merger will be approved by regulators.
Bloomberg Radio, listen! Bloomberg TV, watch! I have a crush on Twitter . Why the rally in retail may not be justified. Parts one and two and three. I am a buyer of Macy's down 10% (or so) from here. I initiated a small J.C. Penney long. I add...